• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL LLC REDIGUARD IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL LLC REDIGUARD IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Model Number IPN038077
Medical Device Problem Code Gas/Air Leak (2946)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/03/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that after the catheter was inserted, the pump alarmed for "possible helium leak" after about 2 minutes.Catheter position was confirmed and the balloon inflation rate was decreased to 35cc.The alarm persisted.The triggering mode was in normal sinus rhythm with a hr of 82.As a result, the catheter was removed and a 2nd catheter was inserted at the same insertion site.Therapy then continued normally.No patient harm or injury.The patient status is reported as "fine".
 
Additional Manufacturer Narrative
Qn#(b)(4).
 
Event or Problem Description
It was reported that after the catheter was inserted, the pump alarmed for "possible helium leak" after about 2 minutes.Catheter position was confirmed and the balloon inflation rate was decreased to 35cc.The alarm persisted.The triggering mode was in normal sinus rhythm with a hr of 82.As a result, the catheter was removed and a 2nd catheter was inserted at the same insertion site.Therapy then continued normally.No patient harm or injury.The patient status is reported as "fine".
 
Additional Manufacturer Narrative
Qn#(b)(4).Returned for investigation was a 40cc 8.0fr rediguard intra-aortic balloon catheter (iabc) without the original packaging.Upon return, the one-way valve was tethered to the short driveline tubing.The bladder was fully unwrapped.No bends, kinks or abnormalities were noted to the returned sample.Dried blood was noted on the exterior surfaces of the returned iabc.No blood was noted within the helium pathway.The bladder thickness was measured at six points with measurements ranging from 0.0063in-0.0070in and was within specification of process document.The one-way valve was tested and passed.A vacuum was pulled on the one-way valve, and it held for at least 1 minute and then 30 seconds five separate times.The iabc central lumen was aspirated and flushed using a 60cc lab-inventory syringe.No abnormalities or debris were noted.The iabc was leak tested and no leaks were detected.Full inflation was achieved.The device passed the leak test.The iabc was connected to an iabp with a lab-inventory 40cc inflation driveline tubing.The iabc was inserted into the "t" tube and 75mmhg backpressure was applied.The iabc was pumped for a minimum of 30 minutes.There were no alarms triggered.The bladder inflated and deflated completely with each beat.The balloon pressure waveform (bpw) was normal.A lab inventory 0.025in guidewire was back loaded through the iabc distal tip.No resistance was noted; the guidewire was able to advance through the central lumen.No blood or debris was noted.The guidewire was front loaded through the iabc luer.No resistance was noted; the guidewire was able to advance through the central lumen.No blood or debris was noted.A device history record (dhr) review was conducted for the lot number with no relevant findings.The device passed all manufacturing specifications prior to release.The reported complaint of iab helium loss alarm is not confirmed.The returned iabc was functionally tested with no leak or abnormalities noted.No alarms were noted during the functional testing.The returned device passed visual and functional test specifications.Based on a review of the device history record (dhr), the product met specification upon release.The root cause of the complaint is undetermined.No further action required at this time.Other remarks: n/a.Corrected data: n/a.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REDIGUARD IAB: 8FR 40CC
Common Device Name
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL LLC
morrisville NC
Manufacturer (Section G)
ARROW INTERNATIONAL INC.
16 elizabeth drive
chelmsford MA 01824
Manufacturer Contact
katharine tarpley
3015 carrington mill blvd
morrisville, NC 27560
MDR Report Key16777232
Report Number3010532612-2023-00218
Device Sequence Number7014627
Product Code DSP
UDI-Device Identifier00801902136732
UDI-Public00801902136732
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K981660
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 04/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/30/2024
Device Model NumberIPN038077
Device Catalogue NumberIAB-S840C
Device Lot Number18F22E0057
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/04/2023
Supplement Date Received by Manufacturer05/24/2023
Initial Report FDA Received Date04/20/2023
Supplement Report FDA Received Date05/26/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/25/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age63 YR
Patient SexMale
Patient Weight72 KG
-
-